BioArctic
kr 305.20Change from previous close: −0.59%Absolute change: −kr 1.80
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- kr 27.08B
- Enterprise value
- kr 25.34B
- P/E (trailing 12 months)
- 260.9
- Forward P/E
- 105.2
- Price/book
- 13.4
- Price/sales
- 27.0
- EV/revenue
- 25.3
Profitability and growth
- Gross margin
- 93.2%
- Operating margin
- -5.8%
- Net margin
- 10.5%
- ROE
- 5.2%
- ROA
- 4.8%
- Revenue growth (year over year)
- -36.9%
Financial health
- Total cash
- kr 1.99B
- Total debt
- kr 90.61M
- Debt/equity
- 0.04
- Current ratio
- 3.99
- Quick ratio
- 2.97
Dividends
- Annual dividend per share
- kr 2.00
- Dividend yield
- 0.6%
- Payout ratio
- 170.9%
- Ex-dividend date
- May 29, 2026
Analysts and estimates
- Average price target
- kr 317.75
- Median price target
- kr 315.00
- High price target
- kr 361.00
- Low price target
- kr 280.00
- Analysts with a price target
- 4
- Consensus
- Buy
- Forward EPS
- kr 2.90
- EPS estimate, current year
- kr 5.72
Shares and trading
- Beta
- -0.69
- Average volume
- 137.46K
- Shares outstanding
- 74.34M
- Float
- 54.58M
- Institutional ownership
- 31.3%
- Insider ownership
- 42.3%